Get Involved
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Study Purpose
This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, spreading, or getting worse. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruitment Criteria
|
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
|
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
| Eligible Ages | 18 Years and Over |
| Gender | All |
Inclusion Criteria:
- - Low- or intermediate-grade neuroendocrine carcinoma, including the following subtypes: carcinoid tumor, low- to intermediate-grade or well- to moderately-differentiated neuroendocrine carcinoma or tumor, atypical carcinoid tumor; documentation from a primary tumor or metastatic site is sufficient; patients with poorly differentiated neuroendocrine carcinoma, high-grade neuroendocrine carcinoma, adenocarcinoid tumor, or goblet cell carcinoid tumor are not eligible.
- - Locally unresectable or metastatic carcinoid tumors.
- - Patients must have histologic documentation or clinical evidence of a carcinoid tumor of primary site (including foregut, midgut, hindgut or other non-pancreatic site); tumors of unknown primary site are eligible provided the treating physician does not suspect medullary thyroid cancer, pancreatic neuroendocrine tumor, paraganglioma, or pheochromocytoma; unknown primary tumors will be classified as small bowel tumors for the purpose of stratification; functional (associated with a clinical syndrome) or nonfunctional tumors are allowed; target lesions must have shown disease progression if therapy included peptide receptor radiotherapy (PRRT) and PRRT must be completed at least 8 weeks prior to registration.
- - Radiological evidence for progressive disease (measurable or non-measurable) within 12 months prior to registration; patients who have received anti-tumor therapy during the past 12 months (including octreotide analogs) must have had radiological documentation of progression of disease while on or after receiving therapy.
- - No known endobronchial lesions and/or lesions infiltrating major pulmonary vessels that increase the risk of pulmonary hemorrhage; patients with lesions infiltrating major pulmonary vessels (contiguous tumor and vessels) are excluded; however, the presence of a tumor that is touching, but not infiltrating (abutting) the vessels is acceptable (computed tomography [CT] with contrast is strongly recommended to evaluate such lesions); patients with large protruding endobronchial lesions in the main or lobar bronchi are excluded; however, endobronchial lesions in the segmented bronchi are allowed.
- - Patients must have measurable disease per RECIST 1.1 by computed tomography (CT) scan or magnetic resonance imaging (MRI); lesions must be accurately measured in at least one dimension (longest diameter to be recorded) as >= 1 cm with CT or MRI (or >= 1.5 cm for lymph nodes); index lesions for the purpose of RECIST 1.1 measurements will not be selected from within the radiation therapy treatment field; however, if there is evidence of disease progression within the radiation treatment field, measurement of the progressing lesions will be documented.
- - No prior treatment with an inhibitor of vascular endothelial growth factor (VEGF) or vascular endothelial growth factor receptor (VEGFR) - Prior treatment (somatostatin analogs excepted) must be completed at least 2 weeks prior to registration; in addition, prior treatment (somatostatin analogs excepted) must be completed at least 4 weeks prior to initiation of study drug; treatment-related toxicities must have improved to =< grade 1 prior to registration, with the exception of alopecia.
- - Concurrent use of somatostatin analogs (SSTa) is allowed, provided that the patient is on a stable dose for at least two months and progressive disease on somatostatin analog has been documented; progression on octreotide is required for patients with tumors arising in the midgut.
- - Prior treatment with embolization (including bland embolization, chemoembolization, and selective internal radiation therapy) or ablative therapies is allowed if measurable disease remains outside of the treated area or there is documented disease progression in a treated site; there is no limit on the prior number of procedures; prior liver-directed or other ablative treatment must be completed at least 8 weeks prior to registration; index lesions for the purpose of RECIST 1.1 measurements will not be selected from within the radiation therapy treatment field; however, if there is evidence of disease progression within the radiation treatment field, measurement of the progressing lesions will be documented.
- - Patients should have completed any major surgery >= 4 weeks prior to registration and must have completed any minor surgery >= 2 weeks prior to registration; patients must have fully recovered from the procedure.
- - The following are examples of procedures considered to be minor: port placement, laparoscopy, thoracoscopy, bronchoscopy, mediastinoscopy, skin biopsies, incisional biopsies, imaging-guided biopsy for diagnostic purposes, and dental extraction procedures.
- - Insertion of a vascular access device, thoracentesis, paracentesis, and endoscopic ultrasonographic procedures are not considered to be major or minor surgeries.
- - No concurrent condition resulting in immune compromise, including chronic treatment with corticosteroids or other immunosuppressive agents.
- - No clinical evidence of central nervous system (CNS) metastases (including carcinomatous meningitis) at baseline, with the exception of those patients who have previously-treated CNS metastases (surgery +/- radiotherapy, radiosurgery, or gamma knife) and who meet both of the following criteria: a) are asymptomatic and b) had no requirement for steroids or enzyme-inducing anticonvulsants within 6 months prior to registration.
- - No history of abdominal fistula, gastrointestinal perforation, or intra-abdominal abscess within 28 days prior to registration.
- - No clinically significant gastrointestinal abnormalities that may increase the risk for gastrointestinal bleeding within 28 days prior to registration including, but not limited to: - Active peptic ulcer.
- - Known endoluminal metastatic lesion(s) with history of bleeding.
- - Inflammatory bowel disease (e.g. ulcerative colitis, Crohn's disease), or other gastrointestinal conditions with increased risk of perforation.
- - No history of serious (i.e., requiring active medical therapy with medication or medical device under the supervision of a physician) non-healing wound, ulcer, trauma, or bone fracture within 28 days prior to study entry.
- - Patients with a history of hypertension must have blood pressure that is adequately controlled on antihypertensives; (< 140/90 mm Hg) - No symptomatic congestive heart failure (New York Heart Association class II, III, or IV) within 6 months prior to registration.
- - No arterial thrombotic events within 6 months of registration, including transient ischemic attack (TIA), cerebrovascular accident (CVA), peripheral arterial thrombus, myocardial infarction (MI), or unstable angina or angina requiring surgical or medical intervention in 6 months prior to registration; patients with clinically significant peripheral artery disease (i.e., claudication on less than one block) are ineligible; patients who have experienced a deep venous thrombosis or pulmonary embolus within 6 months prior to registration must be on stable therapeutic anticoagulation for at least 6 weeks prior to enrollment of this study.
- - Patients on therapeutic anticoagulation with low molecular weight heparins, fondaparinux, rivaroxaban or warfarin are eligible, provided that they are on a stable dose of anticoagulants; patients who are currently receiving antiplatelet therapy of prasugrel or clopidogrel or antiaggregation agents (e.g., eptifibatide, epoprostenol, dipyridamole) or low doses of acetylsalicylic acid (up to 100 mg daily) are also eligible.
- - No ongoing cardiac dysrhythmias, atrial fibrillation, or prolongation of corrected QT (QTc) interval to > 480 msec.
- - No evidence of active bleeding, bleeding diathesis, or hemoptysis (>= 1/2 teaspoon of red blood) within 8 weeks prior to registration.
- - No currently unstable angina and/or uncontrolled cardiac arrhythmias.
- - Patients with symptomatic peripheral vascular disease are ineligible.
- - Ejection fraction on echocardiogram (Echo) or multi gated acquisition scan (MUGA) > 50% - Chronic concomitant treatment with strong inhibitors of cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4) is not allowed on this trial; patients on strong CYP3A4 inhibitors must discontinue the drug 14 days prior to the start of study treatment.
- - Women must not be pregnant or nursing; women of child bearing potential must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of human chorionic gonadotropin [HCG]) within 72 hours prior to registration; women of child-bearing potential include any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy, bilateral tubal ligation or bilateral oophorectomy) or is not postmenopausal (defined as amenorrhea >= 12 consecutive months; or women on hormone replacement therapy [HRT] with documented serum follicle stimulating hormone [FSH] level > 35 mIU/mL) - Age >= 18 years of age.
- - Eastern Cooperative Oncology Group (ECOG) performance status 0-1.
- - Granulocytes >= 1,500/mcL.
- - Platelets >= 100,000/mcL.
- - International normalized ratio (INR) =< 1.2 X upper limit of normal (ULN); only required for patients receiving anticoagulant therapy; patients are eligible if their INR is stable and within the recommended range for the desired level of anticoagulation.
- - QTc =< 480 msecs.
- - Thyroid stimulating hormone (TSH) within normal limits (WNL); medications for thyroid dysfunction are allowed as long as TSH is normal at registration; in patients with abnormal TSH, if the free thyroxine (free T4) and free thyroxine index (FTI) are normal and patient is clinically euthyroid, patient is eligible.
- - Bilirubin =< 1.5 x ULN.
- - Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT]) & alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x ULN; concomitant elevations in bilirubin and AST/ALT above 1.0 X ULN are NOT permitted; also, if liver metastases are present, AST & ALT =< 5 x ULN is allowed.
- - Serum creatinine =< 1.5 x ULN.
Trial Details
|
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT01841736 |
|
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 2 |
|
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
National Cancer Institute (NCI) |
|
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
Emily K Bergsland |
| Principal Investigator Affiliation | Alliance for Clinical Trials in Oncology |
|
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
NIH |
| Overall Status | Active, not recruiting |
| Countries | Canada, United States |
|
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Foregut Neuroendocrine Tumor, Hindgut Neuroendocrine Tumor, Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Neuroendocrine Tumor, Midgut Neuroendocrine Tumor G1, Neuroendocrine Tumor G2, Recurrent Digestive System Neuroendocrine Tumor G1, Regional Digestive System Neuroendocrine Tumor G1 |
PRIMARY OBJECTIVE:
- I. For patients with progressive carcinoid tumors, progression-free survival (PFS defined by central review according to Response Evaluation Criteria in Solid Tumors [RECIST] 1.1) will be compared between patients randomized to treatment with pazopanib (pazopanib hydrochloride) versus placebo.
- I. Overall survival (OS) will be compared between treatment arms.
- II. Objective response rate, duration of response, and time to treatment failure will be compared between treatment arms.
- III. Progression free survival (PFS) as assessed by central radiology review and local radiology review will be compared overall and within treatment arms.
- IV. Safety and tolerability of treatment with pazopanib/placebo will be evaluated within each treatment arm.
- V. PFS and other indicators of efficacy will be estimated in patients who crossover to pazopanib from placebo.
- VI. To determine the turn-around time for timely adjudicated central review.
- VII. To characterize the nature of discordance between local and central radiology review in assessment of progression.
- VIII. To characterize the type and rate of progression in carcinoid (at study entry, on-study, and at progression).
- IX. To develop new methods for modeling carcinoid growth and detecting treatment effects, and to perform simulations that advance new clinical trial designs to apply to future trials of carcinoid therapeutics.
- X. To assess for differences in quality of life (QOL)-related domains between the two treatment groups (pazopanib versus placebo).
- I. PFS at 6 months will be estimated within each treatment arm.
- II. Biochemical response (for chromogranin A, defined as a decrease of 50% or more in chromogranin A levels from baseline and for 5-hydroxyindoleacetic acid [5-HIAA], defined as a decrease of 50% or more in urinary 5-HIAA levels from baseline) will be compared between treatment arms among patients with elevated baseline levels of chromogranin A (CGA) and 5-HIAA.
- I. Patients undergo ECHO or MUGA during screening.
Arms
Experimental: Arm I (pazopanib hydrochloride)
Patients receive pazopanib hydrochloride PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients undergo ECHO or MUGA during screening. Patients also undergo CT, MRI, and chest x-ray throughout the trial. Patients may optionally undergo blood sample collection during screening and on study.
Placebo Comparator: Arm II (placebo)
Patients receive placebo PO QD on days 1-28. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. At the time of progressive disease, patients may cross-over to Arm I. Patients undergo ECHO or MUGA during screening. Patients also undergo CT, MRI, and chest x-ray throughout the trial. Patients may optionally undergo blood sample collection during screening and on study.
Interventions
Procedure: - Biospecimen Collection
Undergo blood sample collection
Procedure: - Computed Tomography
Undergo CT
Procedure: - Echocardiography Test
Undergo ECHO
Other: - Laboratory Biomarker Analysis
Correlative studies
Procedure: - Magnetic Resonance Imaging
Undergo MRI
Procedure: - Multigated Acquisition Scan
Undergo MUGA
Drug: - Pazopanib Hydrochloride
Given PO
Other: - Placebo Administration
Given PO
Other: - Quality-of-Life Assessment
Ancillary studies
Procedure: - X-Ray Imaging
Undergo chest x-ray
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Address
Alaska Breast Care and Surgery LLC
Anchorage 5879400, Alaska 5879092, 99508
Status
Address
Alaska Women's Cancer Care
Anchorage 5879400, Alaska 5879092, 99508
Status
Address
Anchorage Oncology Centre
Anchorage 5879400, Alaska 5879092, 99508
Status
Address
Katmai Oncology Group
Anchorage 5879400, Alaska 5879092, 99508
Status
Address
Providence Alaska Medical Center
Anchorage 5879400, Alaska 5879092, 99508
Status
Address
Mayo Clinic in Arizona
Scottsdale 5313457, Arizona 5551752, 85259
Status
Address
Kaiser Permanente-Anaheim
Anaheim 5323810, California 5332921, 92806
Status
Address
Kaiser Permanente-Baldwin Park
Baldwin Park 5325866, California 5332921, 91706
Status
Address
Kaiser Permanente-Fontana
Fontana 5349755, California 5332921, 92335
Status
Address
Kaiser Permanente South Bay
Harbor City 5355325, California 5332921, 90710
Status
Address
Kaiser Permanente-Irvine
Irvine 5359777, California 5332921, 92618
Status
Address
Kaiser Permanente Los Angeles Medical Center
Los Angeles 5368361, California 5332921, 90027
Status
Address
Los Angeles General Medical Center
Los Angeles 5368361, California 5332921, 90033
Status
Address
USC / Norris Comprehensive Cancer Center
Los Angeles 5368361, California 5332921, 90033
Status
Address
Kaiser Permanente West Los Angeles
Los Angeles 5368361, California 5332921, 90034
Status
Address
Cedars Sinai Medical Center
Los Angeles 5368361, California 5332921, 90048
Status
Address
Palo Alto Medical Foundation Health Care
Palo Alto 5380748, California 5332921, 94301
Status
Address
Stanford Cancer Institute Palo Alto
Palo Alto 5380748, California 5332921, 94304
Status
Address
Kaiser Permanente - Panorama City
Panorama City 5380932, California 5332921, 91402
Status
Address
Kaiser Permanente-Riverside
Riverside 5387877, California 5332921, 92505
Status
Address
Kaiser Permanente-San Diego Mission
San Diego 5391811, California 5332921, 92108
Status
Address
Kaiser Permanente-San Diego Zion
San Diego 5391811, California 5332921, 92120
Status
Address
UCSF Medical Center-Mount Zion
San Francisco 5391959, California 5332921, 94115
Status
Address
UCSF Medical Center-Mission Bay
San Francisco 5391959, California 5332921, 94158
Status
Address
Kaiser Permanente-San Marcos
San Marcos 5392368, California 5332921, 92078
Status
Address
Palo Alto Medical Foundation-Santa Cruz
Santa Cruz 5393052, California 5332921, 95065
Status
Address
Palo Alto Medical Foundation-Sunnyvale
Sunnyvale 5400075, California 5332921, 94086
Status
Address
Kaiser Permanente-Woodland Hills
Woodland Hills 5410438, California 5332921, 91367
Status
Address
The Medical Center of Aurora
Aurora 5412347, Colorado 5417618, 80012
Status
Address
Boulder Community Foothills Hospital
Boulder 5574991, Colorado 5417618, 80303
Status
Address
Rocky Mountain Cancer Centers-Boulder
Boulder 5574991, Colorado 5417618, 80304
Status
Address
Penrose-Saint Francis Healthcare
Colorado Springs 5417598, Colorado 5417618, 80907
Status
Address
Rocky Mountain Cancer Centers-Penrose
Colorado Springs 5417598, Colorado 5417618, 80907
Status
Address
AdventHealth Porter
Denver 5419384, Colorado 5417618, 80210
Status
Address
Colorado Blood Cancer Institute
Denver 5419384, Colorado 5417618, 80218
Status
Address
Presbyterian - Saint Lukes Medical Center - Health One
Denver 5419384, Colorado 5417618, 80218
Status
Address
Rocky Mountain Cancer Centers-Midtown
Denver 5419384, Colorado 5417618, 80218
Status
Address
Saint Joseph Hospital - Cancer Centers of Colorado
Denver 5419384, Colorado 5417618, 80218
Status
Address
Rocky Mountain Cancer Centers-Rose
Denver 5419384, Colorado 5417618, 80220
Status
Address
Rose Medical Center
Denver 5419384, Colorado 5417618, 80220
Status
Address
Western States Cancer Research NCORP
Denver 5419384, Colorado 5417618, 80222
Status
Address
Mercy Medical Center
Durango 5420241, Colorado 5417618, 81301
Status
Address
Mountain Blue Cancer Care Center - Swedish
Englewood 5421250, Colorado 5417618, 80113
Status
Address
Swedish Medical Center
Englewood 5421250, Colorado 5417618, 80113
Status
Address
Poudre Valley Hospital
Fort Collins 5577147, Colorado 5417618, 80524
Status
Address
Mountain Blue Cancer Care Center
Golden 5423294, Colorado 5417618, 80401
Status
Address
Banner North Colorado Medical Center
Greeley 5577592, Colorado 5417618, 80631
Status
Address
Rocky Mountain Cancer Centers-Greenwood Village
Greenwood Village 5423908, Colorado 5417618, 80111
Status
Address
Rocky Mountain Cancer Centers-Lakewood
Lakewood 5427946, Colorado 5417618, 80228
Status
Address
Saint Anthony Hospital
Lakewood 5427946, Colorado 5417618, 80228
Status
Address
AdventHealth Littleton
Littleton 5429032, Colorado 5417618, 80122
Status
Address
Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree 5429208, Colorado 5417618, 80124
Status
Address
Sky Ridge Medical Center
Lone Tree 5429208, Colorado 5417618, 80124
Status
Address
Longmont United Hospital
Longmont 5579276, Colorado 5417618, 80501
Status
Address
Rocky Mountain Cancer Centers-Longmont
Longmont 5579276, Colorado 5417618, 80501
Status
Address
Banner McKee Medical Center
Loveland 5579368, Colorado 5417618, 80539
Status
Address
AdventHealth Parker
Parker 5434006, Colorado 5417618, 80138
Status
Address
Rocky Mountain Cancer Centers-Parker
Parker 5434006, Colorado 5417618, 80138
Status
Address
Saint Mary Corwin Medical Center
Pueblo 5435464, Colorado 5417618, 81004
Status
Address
Rocky Mountain Cancer Centers - Pueblo
Pueblo 5435464, Colorado 5417618, 81008
Status
Address
Intermountain Health Lutheran Hospital
Wheat Ridge 5443948, Colorado 5417618, 80401
Status
Address
Smilow Cancer Hospital Care Center at Saint Francis
Hartford 4835797, Connecticut 4831725, 06105
Status
Address
Beebe Medical Center
Lewes 4143354, Delaware 4142224, 19958
Status
Address
Delaware Clinical and Laboratory Physicians PA
Newark 4143861, Delaware 4142224, 19713
Status
Address
Helen F Graham Cancer Center
Newark 4143861, Delaware 4142224, 19713
Status
Address
Medical Oncology Hematology Consultants PA
Newark 4143861, Delaware 4142224, 19713
Status
Address
Christiana Care Health System-Christiana Hospital
Newark 4143861, Delaware 4142224, 19718
Status
Address
Beebe Health Campus
Rehoboth Beach 4144284, Delaware 4142224, 19971
Status
Address
TidalHealth Nanticoke / Allen Cancer Center
Seaford 4144600, Delaware 4142224, 19973
Status
Address
Christiana Care Health System-Wilmington Hospital
Wilmington 4145381, Delaware 4142224, 19801
Status
Address
Moffitt Cancer Center
Tampa 4174757, Florida 4155751, 33612
Status
Address
John B Amos Cancer Center
Columbus 4188985, Georgia 4197000, 31904
Status
Address
Memorial Health University Medical Center
Savannah 4221552, Georgia 4197000, 31404
Status
Address
Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu 5856195, Hawaii 5855797, 96813
Status
Address
Queen's Medical Center
Honolulu 5856195, Hawaii 5855797, 96813
Status
Address
Straub Clinic and Hospital
Honolulu 5856195, Hawaii 5855797, 96813
Status
Address
University of Hawaii Cancer Center
Honolulu 5856195, Hawaii 5855797, 96813
Status
Address
Hawaii Cancer Care Inc-Liliha
Honolulu 5856195, Hawaii 5855797, 96817
Status
Address
Queen's Cancer Center - Kuakini
Honolulu 5856195, Hawaii 5855797, 96817
Status
Address
Kapiolani Medical Center for Women and Children
Honolulu 5856195, Hawaii 5855797, 96826
Status
Address
Castle Medical Center
Kailua 5847486, Hawaii 5855797, 96734
Status
Address
Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue 5850248, Hawaii 5855797, 96766
Status
Address
Pali Momi Medical Center
‘Aiea 5856430, Hawaii 5855797, 96701
Status
Address
Queen's Cancer Center - Pearlridge
‘Aiea 5856430, Hawaii 5855797, 96701
Status
Address
Saint Alphonsus Cancer Care Center-Boise
Boise 5586437, Idaho 5596512, 83706
Status
Address
Kootenai Clinic Cancer Services - Post Falls
Post Falls 5604353, Idaho 5596512, 83854
Status
Address
Illinois CancerCare-Bloomington
Bloomington 4885164, Illinois 4896861, 61704
Status
Address
Illinois CancerCare-Canton
Canton 4831990, Illinois 4896861, 61520
Status
Address
Illinois CancerCare-Carthage
Carthage 4886716, Illinois 4896861, 62321
Status
Address
Northwestern University
Chicago 4887398, Illinois 4896861, 60611
Status
Address
University of Chicago Comprehensive Cancer Center
Chicago 4887398, Illinois 4896861, 60637
Status
Address
Cancer Care Specialists of Illinois - Decatur
Decatur 4236895, Illinois 4896861, 62526
Status
Address
Decatur Memorial Hospital
Decatur 4236895, Illinois 4896861, 62526
Status
Address
Illinois CancerCare-Eureka
Eureka 4891310, Illinois 4896861, 61530
Status
Address
Illinois CancerCare-Galesburg
Galesburg 4893392, Illinois 4896861, 61401
Status
Address
Ingalls Memorial Hospital
Harvey 4895298, Illinois 4896861, 60426
Status
Address
Illinois CancerCare-Kewanee Clinic
Kewanee 4898433, Illinois 4896861, 61443
Status
Address
Illinois CancerCare-Macomb
Macomb 4900817, Illinois 4896861, 61455
Status
Address
Loyola University Medical Center
Maywood 4901514, Illinois 4896861, 60153
Status
Address
SSM Health Good Samaritan
Mount Vernon 4245152, Illinois 4896861, 62864
Status
Address
Illinois CancerCare-Ottawa Clinic
Ottawa 4905006, Illinois 4896861, 61350
Status
Address
Illinois CancerCare-Pekin
Pekin 4905599, Illinois 4896861, 61554
Status
Address
Illinois CancerCare-Peoria
Peoria 4905687, Illinois 4896861, 61615
Status
Address
Illinois CancerCare-Peru
Peru 4905770, Illinois 4896861, 61354
Status
Address
Illinois CancerCare-Princeton
Princeton 4906818, Illinois 4896861, 61356
Status
Address
Elkhart Clinic
Elkhart 4919987, Indiana 4921868, 46514-2098
Status
Address
Michiana Hematology Oncology PC-Elkhart
Elkhart 4919987, Indiana 4921868, 46514
Status
Address
Elkhart General Hospital
Elkhart 4919987, Indiana 4921868, 46515
Status
Address
Indiana University/Melvin and Bren Simon Cancer Center
Indianapolis 4259418, Indiana 4921868, 46202
Status
Address
Community Howard Regional Health
Kokomo 4922388, Indiana 4921868, 46904
Status
Address
IU Health La Porte Hospital
La Porte 8449910, Indiana 4921868, 46350
Status
Address
Michiana Hematology Oncology PC-Mishawaka
Mishawaka 4923670, Indiana 4921868, 46545
Status
Address
Saint Joseph Regional Medical Center-Mishawaka
Mishawaka 4923670, Indiana 4921868, 46545
Status
Address
Michiana Hematology Oncology PC-Plymouth
Plymouth 4924970, Indiana 4921868, 46563
Status
Address
Reid Health
Richmond 4263681, Indiana 4921868, 47374
Status
Address
Memorial Hospital of South Bend
South Bend 4926563, Indiana 4921868, 46601
Status
Address
South Bend Clinic
South Bend 4926563, Indiana 4921868, 46617
Status
Address
Northern Indiana Cancer Research Consortium
South Bend 4926563, Indiana 4921868, 46628
Status
Address
Michiana Hematology Oncology PC-Westville
Westville 4928145, Indiana 4921868, 46391
Status
Address
Mary Greeley Medical Center
Ames 4846834, Iowa 4862182, 50010
Status
Address
McFarland Clinic - Ames
Ames 4846834, Iowa 4862182, 50010
Status
Address
University of Iowa Healthcare Cancer Services Quad Cities
Bettendorf 4848489, Iowa 4862182, 52722
Status
Address
McFarland Clinic - Boone
Boone 4849051, Iowa 4862182, 50036
Status
Address
Mercy Hospital
Cedar Rapids 4850751, Iowa 4862182, 52403
Status
Address
Oncology Associates at Mercy Medical Center
Cedar Rapids 4850751, Iowa 4862182, 52403
Status
Address
Mercy Cancer Center-West Lakes
Clive 4852065, Iowa 4862182, 50325
Status
Address
UI Health Care Mission Cancer and Blood - West Des Moines Clinic
Clive 4852065, Iowa 4862182, 50325
Status
Address
Iowa Methodist Medical Center
Des Moines 4853828, Iowa 4862182, 50309
Status
Address
Iowa-Wide Oncology Research Coalition NCORP
Des Moines 4853828, Iowa 4862182, 50309
Status
Address
UI Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines 4853828, Iowa 4862182, 50309
Status
Address
Mercy Medical Center - Des Moines
Des Moines 4853828, Iowa 4862182, 50314
Status
Address
UI Health Care Mission Cancer and Blood - Laurel Clinic
Des Moines 4853828, Iowa 4862182, 50314
Status
Address
Iowa Lutheran Hospital
Des Moines 4853828, Iowa 4862182, 50316
Status
Address
University of Iowa/Holden Comprehensive Cancer Center
Iowa City 4862034, Iowa 4862182, 52242
Status
Address
McFarland Clinic - Jefferson
Jefferson 4862482, Iowa 4862182, 50129
Status
Address
McFarland Clinic - Marshalltown
Marshalltown 4866371, Iowa 4862182, 50158
Status
Address
Siouxland Regional Cancer Center
Sioux City 4876523, Iowa 4862182, 51101
Status
Address
Mercy Medical Center-Sioux City
Sioux City 4876523, Iowa 4862182, 51102
Status
Address
Saint Luke's Regional Medical Center
Sioux City 4876523, Iowa 4862182, 51104
Status
Address
Methodist West Hospital
West Des Moines 4881346, Iowa 4862182, 50266-7700
Status
Address
Mercy Medical Center-West Lakes
West Des Moines 4881346, Iowa 4862182, 50266
Status
Address
Newman Regional Health
Emporia 4271086, Kansas 4273857, 66801
Status
Address
Saint Catherine Hospital
Garden City 5445439, Kansas 4273857, 67846
Status
Address
Saint Rose Ambulatory and Surgery Center
Great Bend 4272340, Kansas 4273857, 67530
Status
Address
HaysMed
Hays 4272782, Kansas 4273857, 67601
Status
Address
University of Kansas Cancer Center-West
Kansas City 4273837, Kansas 4273857, 66112
Status
Address
University of Kansas Cancer Center
Kansas City 4273837, Kansas 4273857, 66160
Status
Address
The University of Kansas Cancer Center - Olathe
Olathe 4276614, Kansas 4273857, 66061
Status
Address
Menorah Medical Center
Overland Park 4276873, Kansas 4273857, 66209
Status
Address
University of Kansas Cancer Center-Overland Park
Overland Park 4276873, Kansas 4273857, 66210
Status
Address
Saint Luke's South Hospital
Overland Park 4276873, Kansas 4273857, 66213
Status
Address
Mercy Hospital Pittsburg
Pittsburg 4277241, Kansas 4273857, 66762
Status
Address
Kansas City NCI Community Oncology Research Program
Prairie Village 4277718, Kansas 4273857, 66208
Status
Address
Salina Regional Health Center
Salina 4278890, Kansas 4273857, 67401
Status
Address
University of Kansas Health System Saint Francis Campus
Topeka 4280539, Kansas 4273857, 66606
Status
Address
Cancer Center of Kansas - Wichita
Wichita 4281730, Kansas 4273857, 67214
Status
Address
Oncology Hematology Care Inc-Crestview
Crestview Hills 4289040, Kentucky 6254925, 41017
Status
Address
Baptist Health Hardin
Elizabethtown 4290988, Kentucky 6254925, 42701
Status
Address
Baptist Health Lexington
Lexington 4297983, Kentucky 6254925, 40503
Status
Address
Ochsner Health Center-Summa
Baton Rouge 4315588, Louisiana 4331987, 70809
Status
Address
Ochsner Medical Center Jefferson
New Orleans 4335045, Louisiana 4331987, 70121
Status
Address
Bixby Medical Center
Adrian 4983811, Michigan 5001836, 49221
Status
Address
Hickman Cancer Center
Adrian 4983811, Michigan 5001836, 49221
Status
Address
Michigan Cancer Research Consortium NCORP
Ann Arbor 4984247, Michigan 5001836, 48106
Status
Address
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Ann Arbor 4984247, Michigan 5001836, 48106
Status
Address
Bronson Battle Creek
Battle Creek 4985153, Michigan 5001836, 49017
Status
Address
Corewell Health Dearborn Hospital
Dearborn 4990510, Michigan 5001836, 48124
Status
Address
Henry Ford Health Saint John Hospital
Detroit 4990729, Michigan 5001836, 48236
Status
Address
OSF Saint Francis Hospital and Medical Group
Escanaba 4992232, Michigan 5001836, 49829
Status
Address
Genesys Hurley Cancer Institute
Flint 4992982, Michigan 5001836, 48503
Status
Address
Hurley Medical Center
Flint 4992982, Michigan 5001836, 48503
Status
Address
Cancer Research Consortium of West Michigan NCORP
Grand Rapids 4994358, Michigan 5001836, 49503
Status
Address
Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids 4994358, Michigan 5001836, 49503
Status
Address
Trinity Health Grand Rapids Hospital
Grand Rapids 4994358, Michigan 5001836, 49503
Status
Address
Allegiance Health
Jackson 4997384, Michigan 5001836, 49201
Status
Address
University of Michigan Health - Sparrow Lansing
Lansing 4998830, Michigan 5001836, 48912
Status
Address
Trinity Health Saint Mary Mercy Livonia Hospital
Livonia 4999837, Michigan 5001836, 48154
Status
Address
Mercy Memorial Hospital
Monroe 5002344, Michigan 5001836, 48162
Status
Address
Toledo Clinic Cancer Centers-Monroe
Monroe 5002344, Michigan 5001836, 48162
Status
Address
Trinity Health Muskegon Hospital
Muskegon 5003132, Michigan 5001836, 49444
Status
Address
Corewell Health Lakeland Hospitals - Niles Hospital
Niles 5003514, Michigan 5001836, 49120
Status
Address
Trinity Health Saint Joseph Mercy Oakland Hospital
Pontiac 5006166, Michigan 5001836, 48341
Status
Address
Lake Huron Medical Center
Port Huron 5006233, Michigan 5001836, 48060
Status
Address
Corewell Health Reed City Hospital
Reed City 5006946, Michigan 5001836, 49677
Status
Address
MyMichigan Medical Center Saginaw
Saginaw 5007989, Michigan 5001836, 48601
Status
Address
Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
Saint Joseph 5008327, Michigan 5001836, 49085
Status
Address
Corewell Health Lakeland Hospitals - Saint Joseph Hospital
Saint Joseph 5008327, Michigan 5001836, 49085
Status
Address
Munson Medical Center
Traverse City 5012495, Michigan 5001836, 49684
Status
Address
Henry Ford Health Warren Hospital
Warren 5014051, Michigan 5001836, 48093
Status
Address
Fairview Ridges Hospital
Burnsville 5019767, Minnesota 5037779, 55337
Status
Address
Mercy Hospital
Coon Rapids 5022025, Minnesota 5037779, 55433
Status
Address
Essentia Health Cancer Center
Duluth 5024719, Minnesota 5037779, 55805
Status
Address
Essentia Health Saint Mary's Medical Center
Duluth 5024719, Minnesota 5037779, 55805
Status
Address
Miller-Dwan Hospital
Duluth 5024719, Minnesota 5037779, 55805
Status
Address
Fairview Southdale Hospital
Edina 5025264, Minnesota 5037779, 55435
Status
Address
Unity Hospital
Fridley 5027482, Minnesota 5037779, 55432
Status
Address
Hutchinson Area Health Care
Hutchinson 5030977, Minnesota 5037779, 55350
Status
Address
Minnesota Oncology Hematology PA-Maplewood
Maplewood 5036588, Minnesota 5037779, 55109
Status
Address
Saint John's Hospital - Healtheast
Maplewood 5036588, Minnesota 5037779, 55109
Status
Address
Abbott-Northwestern Hospital
Minneapolis 5037649, Minnesota 5037779, 55407
Status
Address
Hennepin County Medical Center
Minneapolis 5037649, Minnesota 5037779, 55415
Status
Address
Health Partners Inc
Minneapolis 5037649, Minnesota 5037779, 55454
Status
Address
New Ulm Medical Center
New Ulm 5039173, Minnesota 5037779, 56073
Status
Address
North Memorial Medical Health Center
Robbinsdale 5043439, Minnesota 5037779, 55422
Status
Address
Mayo Clinic in Rochester
Rochester 5043473, Minnesota 5037779, 55905
Status
Address
Metro Minnesota Community Oncology Research Consortium
Saint Louis Park 5045021, Minnesota 5037779, 55416
Status
Address
Park Nicollet Clinic - Saint Louis Park
Saint Louis Park 5045021, Minnesota 5037779, 55416
Status
Address
Regions Hospital
Saint Paul 5045360, Minnesota 5037779, 55101
Status
Address
United Hospital
Saint Paul 5045360, Minnesota 5037779, 55102
Status
Address
Saint Francis Regional Medical Center
Shakopee 5046997, Minnesota 5037779, 55379
Status
Address
Lakeview Hospital
Stillwater 5048814, Minnesota 5037779, 55082
Status
Address
Ridgeview Medical Center
Waconia 5051640, Minnesota 5037779, 55387
Status
Address
Rice Memorial Hospital
Willmar 5052916, Minnesota 5037779, 56201
Status
Address
Minnesota Oncology Hematology PA-Woodbury
Woodbury 5053358, Minnesota 5037779, 55125
Status
Address
Cox Cancer Center Branson
Branson 4378219, Missouri 4398678, 65616
Status
Address
Mercy Cancer Center - Cape Girardeau
Cape Girardeau 4379966, Missouri 4398678, 63703
Status
Address
MU Health - University Hospital/Ellis Fischel Cancer Center
Columbia 4381982, Missouri 4398678, 65212
Status
Address
Centerpoint Medical Center LLC
Independence 4391812, Missouri 4398678, 64057
Status
Address
MU Health Care Goldschmidt Cancer Center
Jefferson City 4392388, Missouri 4398678, 65109
Status
Address
Mercy Hospital Joplin
Joplin 4392768, Missouri 4398678, 64804
Status
Address
University Health Truman Medical Center
Kansas City 4393217, Missouri 4398678, 64108
Status
Address
Saint Luke's Hospital of Kansas City
Kansas City 4393217, Missouri 4398678, 64111
Status
Address
Heartland Hematology and Oncology Associates Incorporated
Kansas City 4393217, Missouri 4398678, 64118
Status
Address
The University of Kansas Cancer Center-South
Kansas City 4393217, Missouri 4398678, 64131
Status
Address
Research Medical Center
Kansas City 4393217, Missouri 4398678, 64132
Status
Address
University of Kansas Cancer Center - North
Kansas City 4393217, Missouri 4398678, 64154
Status
Address
University of Kansas Cancer Center - Lee's Summit
Lee's Summit 4394870, Missouri 4398678, 64064
Status
Address
Saint Luke's East - Lee's Summit
Lee's Summit 4394870, Missouri 4398678, 64086
Status
Address
Liberty Hospital
Liberty 4395052, Missouri 4398678, 64068
Status
Address
Mercy Clinic-Rolla-Cancer and Hematology
Rolla 4406282, Missouri 4398678, 65401
Status
Address
Phelps Health Delbert Day Cancer Institute
Rolla 4406282, Missouri 4398678, 65401
Status
Address
Heartland Regional Medical Center
Saint Joseph 4407010, Missouri 4398678, 64506
Status
Address
Cancer Research for the Ozarks NCORP
Springfield 4409896, Missouri 4398678, 65804
Status
Address
Mercy Hospital Springfield
Springfield 4409896, Missouri 4398678, 65804
Status
Address
CoxHealth South Hospital
Springfield 4409896, Missouri 4398678, 65807
Status
Address
Mercy Infusion Center - Chippewa
St Louis 4407066, Missouri 4398678, 63109
Status
Address
Washington University School of Medicine
St Louis 4407066, Missouri 4398678, 63110
Status
Address
Missouri Baptist Medical Center
St Louis 4407066, Missouri 4398678, 63131
Status
Address
Mercy Hospital Saint Louis
St Louis 4407066, Missouri 4398678, 63141
Status
Address
Billings Clinic Cancer Center
Billings 5640350, Montana 5667009, 59101
Status
Address
Saint Vincent Healthcare
Billings 5640350, Montana 5667009, 59101
Status
Address
Montana Cancer Consortium NCORP
Billings 5640350, Montana 5667009, 59102
Status
Address
Bozeman Health Deaconess Hospital
Bozeman 5641727, Montana 5667009, 59715
Status
Address
Saint James Community Hospital and Cancer Treatment Center
Butte 5642934, Montana 5667009, 59701
Status
Address
Benefis Sletten Cancer Institute
Great Falls 5655240, Montana 5667009, 59405
Status
Address
Saint Peter's Community Hospital
Helena 5656882, Montana 5667009, 59601
Status
Address
Logan Health Medical Center
Kalispell 5660340, Montana 5667009, 59901
Status
Address
Saint Patrick Hospital - Community Hospital
Missoula 5666639, Montana 5667009, 59802
Status
Address
Nebraska Cancer Research Center
Lincoln 5072006, Nebraska 5073708, 68510
Status
Address
Missouri Valley Cancer Consortium
Omaha 5074472, Nebraska 5073708, 68106
Status
Address
Nebraska Methodist Hospital
Omaha 5074472, Nebraska 5073708, 68114
Status
Address
Alegent Health Immanuel Medical Center
Omaha 5074472, Nebraska 5073708, 68122
Status
Address
Alegent Health Bergan Mercy Medical Center
Omaha 5074472, Nebraska 5073708, 68124
Status
Address
Alegent Health Lakeside Hospital
Omaha 5074472, Nebraska 5073708, 68130
Status
Address
Creighton University Medical Center
Omaha 5074472, Nebraska 5073708, 68131
Status
Address
Cancer and Blood Specialists-Henderson
Henderson 5505411, Nevada 5509151, 89052
Status
Address
Comprehensive Cancer Centers of Nevada - Henderson
Henderson 5505411, Nevada 5509151, 89052
Status
Address
Las Vegas Cancer Center-Henderson
Henderson 5505411, Nevada 5509151, 89052
Status
Address
Comprehensive Cancer Centers of Nevada-Southeast Henderson
Henderson 5505411, Nevada 5509151, 89074
Status
Address
Oncology Las Vegas - Henderson
Henderson 5505411, Nevada 5509151, 89074
Status
Address
University Medical Center of Southern Nevada
Las Vegas 5506956, Nevada 5509151, 89102
Status
Address
Cancer and Blood Specialists-Shadow
Las Vegas 5506956, Nevada 5509151, 89106
Status
Address
Radiation Oncology Centers of Nevada Central
Las Vegas 5506956, Nevada 5509151, 89106
Status
Address
GenesisCare USA - Las Vegas
Las Vegas 5506956, Nevada 5509151, 89109
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
Las Vegas 5506956, Nevada 5509151, 89109
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-San Martin
Las Vegas 5506956, Nevada 5509151, 89113
Status
Address
Radiation Oncology Centers of Nevada Southeast
Las Vegas 5506956, Nevada 5509151, 89119
Status
Address
Nevada Cancer Research Foundation NCORP
Las Vegas 5506956, Nevada 5509151, 89120
Status
Address
Cancer Therapy and Integrative Medicine
Las Vegas 5506956, Nevada 5509151, 89121
Status
Address
Cancer and Blood Specialists-Tenaya
Las Vegas 5506956, Nevada 5509151, 89128
Status
Address
Comprehensive Cancer Centers of Nevada - Northwest
Las Vegas 5506956, Nevada 5509151, 89128
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Tenaya
Las Vegas 5506956, Nevada 5509151, 89128
Status
Address
Oncology Las Vegas - Tenaya
Las Vegas 5506956, Nevada 5509151, 89128
Status
Address
Comprehensive Cancer Centers of Nevada-Summerlin
Las Vegas 5506956, Nevada 5509151, 89144
Status
Address
Las Vegas Cancer Center-Medical Center
Las Vegas 5506956, Nevada 5509151, 89148-2405
Status
Address
Comprehensive Cancer Centers of Nevada
Las Vegas 5506956, Nevada 5509151, 89148
Status
Address
GenesisCare USA - Fort Apache
Las Vegas 5506956, Nevada 5509151, 89148
Status
Address
OptumCare Cancer Care at Fort Apache
Las Vegas 5506956, Nevada 5509151, 89148
Status
Address
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
Las Vegas 5506956, Nevada 5509151, 89149
Status
Address
Comprehensive Cancer Centers of Nevada - Central Valley
Las Vegas 5506956, Nevada 5509151, 89169
Status
Address
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
Lebanon 5088597, New Hampshire 5090174, 03756
Status
Address
Cooper Hospital University Medical Center
Camden 4501018, New Jersey 5101760, 08103
Status
Address
Rutgers Cancer Institute of New Jersey
New Brunswick 5101717, New Jersey 5101760, 08903
Status
Address
University of New Mexico Cancer Center
Albuquerque 5454711, New Mexico 5481136, 87106
Status
Address
Memorial Medical Center-Las Cruces
Las Cruces 5475352, New Mexico 5481136, 88011
Status
Address
Glens Falls Hospital
Glens Falls 5118693, New York 5128638, 12801
Status
Address
University of Rochester
Rochester 5134086, New York 5128638, 14642
Status
Address
Syracuse Veterans Administration Medical Center
Syracuse 5140405, New York 5128638, 13210
Status
Address
Montefiore Medical Center-Einstein Campus
The Bronx 5110266, New York 5128638, 10461
Status
Address
Montefiore Medical Center - Moses Campus
The Bronx 5110266, New York 5128638, 10467
Status
Address
UNC Lineberger Comprehensive Cancer Center
Chapel Hill 4460162, North Carolina 4482348, 27599
Status
Address
Wayne Memorial Hospital
Goldsboro 4468261, North Carolina 4482348, 27534
Status
Address
Margaret R Pardee Memorial Hospital
Hendersonville 4470592, North Carolina 4482348, 28791
Status
Address
ECU Health Oncology Kinston
Kinston 4474436, North Carolina 4482348, 28501
Status
Address
Iredell Memorial Hospital
Statesville 4493316, North Carolina 4482348, 28677
Status
Address
Essentia Health Cancer Center-South University Clinic
Fargo 5059163, North Dakota 5690763, 58103
Status
Address
Strecker Cancer Center-Belpre
Belpre 4506187, Ohio 5165418, 45714
Status
Address
Toledo Clinic Cancer Centers-Bowling Green
Bowling Green 5147968, Ohio 5165418, 43402
Status
Address
Adena Regional Medical Center
Chillicothe 4828890, Ohio 5165418, 45601
Status
Address
Oncology Hematology Care Inc-Eden Park
Cincinnati 4508722, Ohio 5165418, 45202
Status
Address
Oncology Hematology Care Inc-Mercy West
Cincinnati 4508722, Ohio 5165418, 45211
Status
Address
Oncology Hematology Care Inc-Anderson
Cincinnati 4508722, Ohio 5165418, 45230
Status
Address
Oncology Hematology Care Inc-Kenwood
Cincinnati 4508722, Ohio 5165418, 45236
Status
Address
Oncology Hematology Care Inc-Blue Ash
Cincinnati 4508722, Ohio 5165418, 45242
Status
Address
Case Western Reserve University
Cleveland 5150529, Ohio 5165418, 44106
Status
Address
Ohio State University Comprehensive Cancer Center
Columbus 4509177, Ohio 5165418, 43210
Status
Address
Columbus Oncology and Hematology Associates Inc
Columbus 4509177, Ohio 5165418, 43214
Status
Address
Riverside Methodist Hospital
Columbus 4509177, Ohio 5165418, 43214
Status
Address
Columbus NCI Community Oncology Research Program
Columbus 4509177, Ohio 5165418, 43215
Status
Address
Grant Medical Center
Columbus 4509177, Ohio 5165418, 43215
Status
Address
The Mark H Zangmeister Center
Columbus 4509177, Ohio 5165418, 43219
Status
Address
Mount Carmel Health Center West
Columbus 4509177, Ohio 5165418, 43222
Status
Address
Doctors Hospital
Columbus 4509177, Ohio 5165418, 43228
Status
Address
Good Samaritan Hospital - Dayton
Dayton 4509884, Ohio 5165418, 45406
Status
Address
Miami Valley Hospital
Dayton 4509884, Ohio 5165418, 45409
Status
Address
Miami Valley Hospital North
Dayton 4509884, Ohio 5165418, 45415
Status
Address
Dayton NCI Community Oncology Research Program
Dayton 4509884, Ohio 5165418, 45459
Status
Address
Delaware Health Center-Grady Cancer Center
Delaware 5151891, Ohio 5165418, 43015
Status
Address
Delaware Radiation Oncology
Delaware 5151891, Ohio 5165418, 43015
Status
Address
Grady Memorial Hospital
Delaware 5151891, Ohio 5165418, 43015
Status
Address
Oncology Hematology Care Inc-Healthplex
Fairfield 4511283, Ohio 5165418, 45014
Status
Address
Blanchard Valley Hospital
Findlay 5153924, Ohio 5165418, 45840
Status
Address
Atrium Medical Center-Middletown Regional Hospital
Franklin 4512203, Ohio 5165418, 45005-1066
Status
Address
Wayne Hospital
Greenville 5156493, Ohio 5165418, 45331
Status
Address
Kettering Medical Center
Kettering 4515843, Ohio 5165418, 45429
Status
Address
Fairfield Medical Center
Lancaster 4516233, Ohio 5165418, 43130
Status
Address
Lancaster Radiation Oncology
Lancaster 4516233, Ohio 5165418, 43130
Status
Address
Lima Memorial Hospital
Lima 5160783, Ohio 5165418, 45804
Status
Address
Marietta Memorial Hospital
Marietta 4517586, Ohio 5165418, 45750
Status
Address
Toledo Clinic Cancer Centers-Maumee
Maumee 5162137, Ohio 5165418, 43537
Status
Address
Toledo Radiation Oncology at Northwest Ohio Onocolgy Center
Maumee 5162137, Ohio 5165418, 43537
Status
Address
Knox Community Hospital
Mount Vernon 5163799, Ohio 5165418, 43050
Status
Address
Licking Memorial Hospital
Newark 5164466, Ohio 5165418, 43055
Status
Address
Newark Radiation Oncology
Newark 5164466, Ohio 5165418, 43055
Status
Address
Saint Charles Hospital
Oregon 5165734, Ohio 5165418, 43616
Status
Address
Toledo Clinic Cancer Centers-Oregon
Oregon 5165734, Ohio 5165418, 43616
Status
Address
Southern Ohio Medical Center
Portsmouth 4521816, Ohio 5165418, 45662
Status
Address
Springfield Regional Medical Center
Springfield 4525353, Ohio 5165418, 45504
Status
Address
ProMedica Flower Hospital
Sylvania 5173572, Ohio 5165418, 43560
Status
Address
Mercy Hospital of Tiffin
Tiffin 5173930, Ohio 5165418, 44883
Status
Address
Mercy Health - Saint Vincent Hospital
Toledo 5174035, Ohio 5165418, 43608
Status
Address
University of Toledo
Toledo 5174035, Ohio 5165418, 43614
Status
Address
Toledo Community Hospital Oncology Program CCOP
Toledo 5174035, Ohio 5165418, 43617
Status
Address
Mercy Health - Saint Anne Hospital
Toledo 5174035, Ohio 5165418, 43623
Status
Address
Toledo Clinic Cancer Centers-Toledo
Toledo 5174035, Ohio 5165418, 43623
Status
Address
Upper Valley Medical Center
Troy 5174358, Ohio 5165418, 45373
Status
Address
Fulton County Health Center
Wauseon 5175877, Ohio 5165418, 43567
Status
Address
Saint Ann's Hospital
Westerville 5176472, Ohio 5165418, 43081
Status
Address
Genesis Healthcare System Cancer Care Center
Zanesville 4528923, Ohio 5165418, 43701
Status
Address
Cancer Centers of Southwest Oklahoma Research
Lawton 4540737, Oklahoma 4544379, 73505
Status
Address
University of Oklahoma Health Sciences Center
Oklahoma City 4544349, Oklahoma 4544379, 73104
Status
Address
Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa 4553433, Oklahoma 4544379, 74146
Status
Address
Clackamas Radiation Oncology Center
Clackamas 5719308, Oregon 5744337, 97015
Status
Address
Providence Milwaukie Hospital
Milwaukie 5740900, Oregon 5744337, 97222
Status
Address
Providence Newberg Medical Center
Newberg 5742726, Oregon 5744337, 97132
Status
Address
Providence Willamette Falls Medical Center
Oregon City 5744253, Oregon 5744337, 97045
Status
Address
Providence Portland Medical Center
Portland 5746545, Oregon 5744337, 97213
Status
Address
Providence Saint Vincent Medical Center
Portland 5746545, Oregon 5744337, 97225
Status
Address
Saint Luke's University Hospital-Bethlehem Campus
Bethlehem 5180225, Pennsylvania 6254927, 18015
Status
Address
Geisinger Medical Center
Danville 5186327, Pennsylvania 6254927, 17822
Status
Address
Geisinger Medical Center-Cancer Center Hazleton
Hazleton 5193011, Pennsylvania 6254927, 18201
Status
Address
Guthrie Medical Group PC-Robert Packer Hospital
Sayre 5211037, Pennsylvania 6254927, 18840
Status
Address
Geisinger Medical Group
State College 5213681, Pennsylvania 6254927, 16801
Status
Address
Geisinger Wyoming Valley/Henry Cancer Center
Wilkes-Barre 5219488, Pennsylvania 6254927, 18711
Status
Address
UPMC Susquehanna
Williamsport 5219585, Pennsylvania 6254927, 17701
Status
Address
Prisma Health Cancer Institute - Spartanburg
Boiling Springs 4571805, South Carolina 4597040, 29316
Status
Address
McLeod Regional Medical Center
Florence 4578737, South Carolina 4597040, 29506
Status
Address
Prisma Health Cancer Institute - Butternut
Greenville 4580543, South Carolina 4597040, 29605
Status
Address
Prisma Health Cancer Institute - Faris
Greenville 4580543, South Carolina 4597040, 29605
Status
Address
Prisma Health Greenville Memorial Hospital
Greenville 4580543, South Carolina 4597040, 29605
Status
Address
Prisma Health Cancer Institute - Eastside
Greenville 4580543, South Carolina 4597040, 29615
Status
Address
Prisma Health Cancer Institute - Greer
Greer 4580599, South Carolina 4597040, 29650
Status
Address
Prisma Health Cancer Institute - Seneca
Seneca 4595346, South Carolina 4597040, 29672
Status
Address
Rapid City Regional Hospital
Rapid City 5768233, South Dakota 5769223, 57701
Status
Address
Baylor University Medical Center
Dallas 4684888, Texas 4736286, 75246
Status
Address
Houston Methodist Hospital
Houston 4699066, Texas 4736286, 77030
Status
Address
University of Texas Health Science Center at San Antonio
San Antonio 4726206, Texas 4736286, 78229
Status
Address
American Fork Hospital / Huntsman Intermountain Cancer Center
American Fork 5844096, Utah 5549030, 84003
Status
Address
Sandra L Maxwell Cancer Center
Cedar City 5536630, Utah 5549030, 84720
Status
Address
Logan Regional Hospital
Logan 5777544, Utah 5549030, 84321
Status
Address
Intermountain Medical Center
Murray 5778755, Utah 5549030, 84107
Status
Address
McKay-Dee Hospital Center
Ogden 5779206, Utah 5549030, 84403
Status
Address
Utah Valley Regional Medical Center
Provo 5780026, Utah 5549030, 84604
Status
Address
Utah Cancer Specialists-Salt Lake City
Salt Lake City 5780993, Utah 5549030, 84106
Status
Address
LDS Hospital
Salt Lake City 5780993, Utah 5549030, 84143
Status
Address
Saint George Regional Medical Center
St. George 5546220, Utah 5549030, 84770
Status
Address
Southwestern Vermont Medical Center
Bennington 5233742, Vermont 5242283, 05201
Status
Address
Fredericksburg Oncology Inc
Fredericksburg 4760059, Virginia 6254928, 22401
Status
Address
PeaceHealth Southwest Medical Center
Vancouver 5814616, Washington 5815135, 98664
Status
Address
Compass Oncology Vancouver
Vancouver 5814616, Washington 5815135, 98684
Status
Address
Edwards Comprehensive Cancer Center
Huntington 4809537, West Virginia 4826850, 25701
Status
Address
Marshfield Clinic-Chippewa Center
Chippewa Falls 5248511, Wisconsin 5279468, 54729
Status
Address
HSHS Sacred Heart Hospital
Eau Claire 5251436, Wisconsin 5279468, 54701
Status
Address
Marshfield Clinic Cancer Center at Sacred Heart
Eau Claire 5251436, Wisconsin 5279468, 54701
Status
Address
Green Bay Oncology at Saint Vincent Hospital
Green Bay 5254962, Wisconsin 5279468, 54301-3526
Status
Address
Saint Vincent Hospital Cancer Center Green Bay
Green Bay 5254962, Wisconsin 5279468, 54301
Status
Address
Saint Vincent Hospital Cancer Center at Saint Mary's
Green Bay 5254962, Wisconsin 5279468, 54303
Status
Address
University of Wisconsin Carbone Cancer Center - University Hospital
Madison 5261457, Wisconsin 5279468, 53792
Status
Address
Holy Family Memorial Hospital
Manitowoc 5261585, Wisconsin 5279468, 54221
Status
Address
Marshfield Medical Center-Marshfield
Marshfield 5261969, Wisconsin 5279468, 54449
Status
Address
Marshfield Medical Center
Marshfield 5261969, Wisconsin 5279468, 54449
Status
Address
Medical College of Wisconsin
Milwaukee 5263045, Wisconsin 5279468, 53226
Status
Address
Marshfield Medical Center - Minocqua
Minocqua 5263156, Wisconsin 5279468, 54548
Status
Address
Cancer Center of Western Wisconsin
New Richmond 5264475, Wisconsin 5279468, 54017
Status
Address
Saint Vincent Hospital Cancer Center at Oconto Falls
Oconto Falls 5265522, Wisconsin 5279468, 54154
Status
Address
Aspirus Cancer Care - James Beck Cancer Center
Rhinelander 5268720, Wisconsin 5279468, 54501
Status
Address
Saint Mary's Hospital
Rhinelander 5268720, Wisconsin 5279468, 54501
Status
Address
Marshfield Medical Center-Rice Lake
Rice Lake 5268798, Wisconsin 5279468, 54868
Status
Address
HSHS Saint Nicholas Hospital
Sheboygan 5272893, Wisconsin 5279468, 53081
Status
Address
Aspirus Cancer Care - Stevens Point
Stevens Point 5274644, Wisconsin 5279468, 54481
Status
Address
Marshfield Clinic-Wausau Center
Wausau 5278120, Wisconsin 5279468, 54401
Status
Address
Marshfield Medical Center - Weston
Weston 5278693, Wisconsin 5279468, 54476
Status
Address
Marshfield Clinic - Wisconsin Rapids Center
Wisconsin Rapids 5279436, Wisconsin 5279468, 54494
Status
Address
Rocky Mountain Oncology
Casper 5820705, Wyoming 5843591, 82609
Status
Address
Welch Cancer Center
Sheridan 5838198, Wyoming 5843591, 82801
International Sites
Status
Address
Arthur J E Child Comprehensive Cancer Centre
Calgary 5913490, Alberta 5883102, T2N 5G2
Status
Address
BCCA-Vancouver Cancer Centre
Vancouver 6173331, British Columbia 5909050, V5Z 4E6
Status
Address
The Vitalite Health Network - Dr Leon Richard Oncology Centre
Moncton 6076211, New Brunswick 6087430, E1C 8X3
Status
Address
QEII Health Sciences Centre/Nova Scotia Health Authority
Halifax 6324729, Nova Scotia 6091530, B3H 2Y9
Status
Address
Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton 5969782, Ontario 6093943, L8V 5C2
Status
Address
Waterloo Regional Health Network
Kitchener 5992996, Ontario 6093943, N2G 1G3
Status
Address
Ottawa Hospital and Cancer Center-General Campus
Ottawa 6094817, Ontario 6093943, K1H 8L6
Status
Address
University Health Network-Princess Margaret Hospital
Toronto 6167865, Ontario 6093943, M5G 2M9
Status
Address
CHUM - Centre Hospitalier de l'Universite de Montreal
Montreal 6077243, Quebec 6115047, H2X 3E4
Status
Address
Allan Blair Cancer Centre
Regina 6119109, Saskatchewan 6141242, S4T 7T1
Status
Address
Saskatoon Cancer Centre
Saskatoon 6141256, Saskatchewan 6141242, S7N 4H4
